Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-31

Clinical Trial Update: WPMDE1 - Whey Protein Milk-Derived Exosomes Among Healthy Subjects [NA]

View source ↗

Summary

Clinical trial update for WPMDE1, whey protein milk-derived exosomes, in healthy subjects; the study listing includes inflammatory bowel disease as a condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WPMDE1 (Whey protein milk-derived exosomes)

Snippet

Sponsor: Exosomm Ltd. | Conditions: IBD | NA | Status: COMPLETED